Transaction made pursuant to a Rule 10b5-1 rdinplan executed on May 1, 2013.
The reporting person and his spouse act as trustees for the Bienaime Family Trust.
The price in column 4 is a weighted average price. The price actually received ranged from $68.29 to $69.10. The reporting person will provide to the issuer, any security holder of the issuer, ot th SEC staff, upon request, information regarding the number of shares sold at rach price within the range.
The reporting person's spouse is trustee of each child's trust.
Original option grant vests 6/48th on November 11, 2006, and 1/48th on the 11th day of every month thereafter
Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever BioMarin Pharmaceutical Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
BioMarin Pharmaceutical Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 6, 2014
BioMarin Pharmaceutical: Entry Into A Material Definitive Agreement - March 6, 2014
EVP of BioMarin Pharmaceutical Inc. just cashed-in 8,000 options - March 5, 2014
BioMarin Pharmaceutical Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 4, 2014